Reproducibility of Lymphoscintigraphy for Lymphatic Mapping in Cutaneous Melanoma

Journal of Nuclear Medicine

Volumn 37, Issue 6, 1996, Pages 972-975

  Kapteijn, B Acca E ^a   Nieweg, Omgo E ^a   Renato, A ^a   Olmos, Valdés ^a   Liem, Ing Han ^a   Robert, K L ^a   Panday, Baidjnath ^a   Hoefnagel, Cornells A ^a   Kroon, Bin B R ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Lymphoscintigraphy; Melanoma; Sentinel node

Indexed keywords

DIAGNOSTIC AGENT; MACROSALB TC 99M;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LYMPH NODE; MALE; MELANOMA; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING; SKIN TUMOR;

ADULT; AGED; FEMALE; HUMANS; LYMPH NODES; MALE; MELANOMA; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SKIN NEOPLASMS; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 0030161909     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Balch CM, Soong SJ, Shaw HM, et al. Changing trends in the clinical and pathologic features of melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ, eds. Cutaneous melanoma, 2nd ed. Philadelphia: J. B. Lippincott: 1992:40-45.
2. McNeer G, Das Gupta TK. Prognosis in malignant melanoma. Surgery 1964;56:512-518.
3. Karakousis CP, Emrich LJ, Rao U. Groin dissection in malignant melanoma. Am J Surg 1986;152:491-495.
4. Das Gupta TK. Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study. Arch Surg 1977;186:201-209.
5. Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg 1981;193:377-388.
6. Roses DF, Provet JA, Harris MN, Gumport SL, Dubin N. Prognosis of patients with pathologic stage II cutaneous malignant melanoma. Ann Surg 1985;201:103-107.
7. Cohen MH, Ketcham AS, Felix EL, et al. Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg 1977;186:635-642.
8. Kroon BBR, Jonk A. Elective lymph node dissection in melanoma: still a controversial issue. Neth J Surg 1991;43:129-132.
9. Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 1977;297:627-630.
10. Veronesi U, Adamus J, Bandiera DC, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982;49:2420-2430.
11. Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 1986;61:697-705.
12. Balch CM. The role of elective lymph node dissection in melanoma: rationale, results and controversies. J Clin Oncol 1988;6:163-172.
13. Balch CM, Soong SJ, Milton GW, et al. A comparison of prognostic factors and surgical results in 1,786 patients with localised (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 1982;196:677-684.
14. Drepper H, Kohler CO, Bastian B, et al. Benefit of elective lymph node dissection in subgroups of melanoma patients. Cancer 1993;72:741-749.
15. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
16. Little JH, Davis NC. Secondary malignant melanoma in lymph nodes: incidence, time of occurrence and mortality. Aust NZ J Surg 1978;48:9-13.
17. O'Rourke MGE, Altman CR. Melanoma recurrence after excision. Is a wide margin justified? Ann Surg 1993,217:2-5.
18. Balch CM, Murad TM, Soong SJ, Ingalls AL, Richards PC, Maddox WA. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer 1979;43:883-888.
19. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-767.
20. Uren RF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH. Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 1993;34:1435-1440.
21. West JH, Seymour JC, Drane WE. Combined transmission-emission imaging in lymphoscintigraphy. Clin Nucl Med 1993;18:762-764.
22. Mudun A, Murray D, Herda S, et al. Reproducibility of lymphoscintigraphy and intraoperative surgical probe use to identify the sentinel node in patients with melanoma [Abstract]. J Nucl Med 1995;36(suppl):263P.
23. Bergqvist L, Strand SB, Persson BRR. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents. Semin Nucl Med 1983;13:9-19.
24. Hotze A, Mahlstedt J, Wolf F. Radiopharmaceuticals for bone marrow imaging. In: Mahlstedt J, ed. Bone marrow imaging. Darmstadt: GIT Verlag Ernst Giebeler; 1984:5-7.
25. Sappey MPC. Injection preparation et conservation des vaisseaux lymphtiques. PhD thesis. Paris; Rignoux Imprimeur de la Faculte de Medecine; 1843.
26. Haagensen CD, ed The lymphatics in cancer. Philadelphia: W.B. Saunders; 1972:437-458.
27. Wahl RL, Geatti O, Liebert M, Wilson B, Shreve P, Beers BA. Kinetics of interstitially administered monoclonal antibodies for purposes of lymphoscintigraphy. J Nucl Med 1987;28:1736-1744.
28. Morton DL, Wen D-R, Foshag LJ, Essner R, Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 1993,11:1751-1756.
29. Ross MI, Reintgen D, Balch CM. Selective lymphadenectomy: Emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol 1993;9:219-223.
30. Lingam MK, Mackie RM, McKay AJ. Intraoperative lymphatic mapping using patent blue V dye to identify regional micrometastasis in limb malignant melanoma [Abstract]. Eur J Surg Oncol 1994;20:332.
31. Uren RF, Howman-Giles R, Thompson JF, et al. Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma. Melanoma Res 1994;4:395-399.
32. Mansfield PF, Lee JF, Balch CM. Cutaneous melanoma: current practice and surgical controversies. Curr Probl Surg 1994;31:253-384.